Botanix Pharmaceuticals Limited (ASX:BOT) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Botanix Pharmaceuticals Limited engages ...

Botanix (ASX:BOT) has reported the first prescriptions of its drug Sofdra (sofpironium) to treat hyperhidrosis, a condition of excessive sweating. According to Botanix, the first prescriptions ...

Botanix has recently been included in the ASX 300, which is part of the company's focus to be the world's largest and most innovative dermatology company. Tune in as Tylah discusses this new ...

Botanix elevated to S&P/ASX 300 index with share price more than doubling in past year Company’s Sofdra treatment for excessive underarm sweating approved by US FDA in June 2024 After a soft ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Botanix has recently been included in the ASX 300, which is part of the company's focus to be the ...